{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:40:04Z","timestamp":1788316804355,"version":"build-2803163510"},"reference-count":150,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1053\/sarh.2001.19819","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"299-312","source":"Crossref","is-referenced-by-count":112,"title":["Treatment of Beh\u00e7et's disease\u2014An update"],"prefix":"10.1053","volume":"30","author":[{"given":"Virginia G.","family":"Kaklamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phaedon G.","family":"Kaklamanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/sarh.2001.19819_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","article-title":"Beh\u00e7et's disease","volume":"27","author":"Kaklamani","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib2","first-page":"145","article-title":"Recent epidemiological features of Beh\u00e7et's disease in Japan","author":"Nakae","year":"1993"},{"key":"10.1053\/sarh.2001.19819_bib3","first-page":"165","article-title":"Risk factors for vital organ involvement in Beh\u00e7et's disease","author":"Dilsen","year":"1993"},{"key":"10.1053\/sarh.2001.19819_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","article-title":"Epidemiological features of Adamantiades-Beh\u00e7et's disease in Germany and in Europe","volume":"38","author":"Zouboulis","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1053\/sarh.2001.19819_bib5","first-page":"2","article-title":"Beh\u00e7et's disease\u2014analysis of 3443 cases","volume":"1","author":"Davatchi","year":"1997","journal-title":"APLAR J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Beh\u00e7et's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sarh.2001.19819_bib7","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/rheumatology\/38.12.1171","article-title":"Beh\u00e7et's syndrome","volume":"38","author":"Barnes","year":"1999","journal-title":"Rheumatology"},{"key":"10.1053\/sarh.2001.19819_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(99)70523-2","article-title":"Beh\u00e7et's disease and complex aphthosis","volume":"40","author":"Ghate","year":"1999","journal-title":"J Amer Acad Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib9","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib10","series-title":"Beh\u00e7et's disease","first-page":"212","author":"Davatchi","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib11","first-page":"2511","article-title":"Is there a place for large vessel disease in the diagnostic criteria of Beh\u00e7et's disease?","volume":"26","author":"Schirmer","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1053\/sarh.2001.19819_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000060761","article-title":"Medical management of Beh\u00e7et's syndrome","volume":"31","author":"Yazici","year":"1999","journal-title":"Dev Ophthalmol"},{"key":"10.1053\/sarh.2001.19819_bib14","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/ndt\/13.12.3002","article-title":"Management of the patient with Beh\u00e7et's disease","volume":"13","author":"Akpolat","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/sarh.2001.19819_bib15","first-page":"31","article-title":"Treatment of Beh\u00e7et's disease","volume":"4","author":"Hashimoto","year":"1992","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib16","first-page":"267","article-title":"Corticosteroids and azathioprine: their use in Beh\u00e7et's syndrome","author":"Lessof","year":"1979"},{"key":"10.1053\/sarh.2001.19819_bib17","first-page":"299","article-title":"Joint manifestations in Beh\u00e7et's disease. A review of 340 cases","volume":"65","author":"Benamour","year":"1998","journal-title":"Revue du Rhumatisme (Eng ed)"},{"key":"10.1053\/sarh.2001.19819_bib18","series-title":"Beh\u00e7et's disease","first-page":"471","author":"Bang","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF02889622","article-title":"Beh\u00e7et's disease: an update","volume":"25","author":"Ehrlich","year":"1999","journal-title":"Comp Ther"},{"key":"10.1053\/sarh.2001.19819_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archneur.1989.00520390031011","article-title":"Neurological involvement in Beh\u00e7et's syndrome: a prospective study","volume":"46","author":"Serdaroglu","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1053\/sarh.2001.19819_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","article-title":"Practical treatment recommendations for pharmacotherapy of Beh\u00e7et's syndrome","volume":"42","author":"Yazici","year":"1991","journal-title":"Drugs"},{"key":"10.1053\/sarh.2001.19819_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/rheumatology\/33.1.48","article-title":"Pulmonary arterial aneurysms in Beh\u00e7et's syndrome: a report of 24 cases","volume":"33","author":"Hamuryudan","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archneur.1996.00550070133022","article-title":"Seven-year follow-up of neurologic involvement in Beh\u00e7et's syndrome","volume":"53","author":"Akman-Demir","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1053\/sarh.2001.19819_bib24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archinte.1989.00390040123025","article-title":"Multiple, large aneurysms of pulmonary arteries in Beh\u00e7et's disease. Clinical remission and radiologic resolution after corticosteroid therapy","volume":"149","author":"Stricker","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1053\/sarh.2001.19819_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08830189709116844","article-title":"Immunotherapy for Beh\u00e7et's disease","volume":"14","author":"Mochizuki","year":"1997","journal-title":"Intern Rev Immunol"},{"key":"10.1053\/sarh.2001.19819_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02032350","article-title":"Efficacy of oxaprozin in the treatment of articular symptoms of Beh\u00e7et's disease","volume":"3","author":"Takeuchi","year":"1984","journal-title":"Clin Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-4362.1991.tb05883.x","article-title":"Treatment of Beh\u00e7et's disease with indomethacin","volume":"30","author":"Simsek","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib28","first-page":"493","article-title":"Inefficacy of azapropazone in the acute arthritis of Beh\u00e7et's syndrome: a randomized, double blind, placebo controlled study","volume":"13","author":"Moral","year":"1995","journal-title":"Clin Exper Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/ard.42.5.505","article-title":"The arthritis of Beh\u00e7et's disease: a prospective study","volume":"42","author":"Yurdakul","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sarh.2001.19819_bib30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(75)80031-6","article-title":"Leucocyte movement and colchicine treatment in Beh\u00e7et's disease (abstr)","volume":"2","author":"Matsumura","year":"1975","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.1981.tb01713.x","article-title":"Colchicine in the treatment of cutaneous manifestations of Beh\u00e7et's disease","volume":"104","author":"Miyachi","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib32","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(77)92945-2","article-title":"Colchicine in Beh\u00e7et's disease (letter)","volume":"2","author":"Mizushima","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib33","first-page":"399","article-title":"A double blind study of colchicine in Beh\u00e7et's disease","volume":"65","author":"Aktulga","year":"1980","journal-title":"Haematologica"},{"key":"10.1053\/sarh.2001.19819_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Beh\u00e7et's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib35","first-page":"148","article-title":"Long-term effects of cyclophosphamide and colchicine treatment in Beh\u00e7et's disease","volume":"23","author":"Kazokoglu","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"10.1053\/sarh.2001.19819_bib36","first-page":"239","article-title":"Combined ciclosporin and colchicine therapy for uveitis in Beh\u00e7et's disease (abstr)","author":"Kotake","year":"1998"},{"issue":"suppl","key":"10.1053\/sarh.2001.19819_bib37","first-page":"S356","article-title":"A double blind study of colchicine in Beh\u00e7et's syndrome (BS) (abstr)","volume":"41","author":"Yurdakul","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib38","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0140-6736(83)90414-2","article-title":"Cyclosporin in Behcet's disease (letter)","volume":"2","author":"French-Constant","year":"1983","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib39","first-page":"454","article-title":"Cyclosporin in Beh\u00e7et's disease","volume":"2","author":"Sanders","year":"1983","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780280611","article-title":"Effectiveness of cyclosporine therapy for Beh\u00e7et's disease","volume":"28","author":"Nussenblatt","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/art.1780290420","article-title":"Cyclosporine A is effective, but not safe, in the management of Beh\u00e7et's disease (letter)","volume":"29","author":"Wechsler","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/26.4.285","article-title":"Cyclosporin A in the treatment of severe Beh\u00e7et's uveitis","volume":"26","author":"Binder","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bjo.71.5.387","article-title":"Short term cyclosporin A treatment of Beh\u00e7et's disease","volume":"71","author":"Mutuoglu","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1053\/sarh.2001.19819_bib44","first-page":"111","article-title":"Cyclosporine in Beh\u00e7et's disease resistant to conventional therapy","volume":"21","author":"Caspers-Velu","year":"1989","journal-title":"Ann Opthalmol"},{"key":"10.1053\/sarh.2001.19819_bib45","first-page":"887","article-title":"La macula dans le syndrome d'Adamantiades-Beh\u00e7et","volume":"12","author":"Palimeris","year":"1989","journal-title":"J Fr Opthalmol"},{"key":"10.1053\/sarh.2001.19819_bib46","first-page":"229","article-title":"Cyclosporin-A-therapie des Morbus Beh\u00e7et","volume":"41","author":"Busch","year":"1990","journal-title":"Hautarzt"},{"key":"10.1053\/sarh.2001.19819_bib47","first-page":"507","article-title":"A retrospective study of therapeutic response and visual outcome in patients with eye disease","author":"Dinning","year":"1991"},{"key":"10.1053\/sarh.2001.19819_bib48","first-page":"613","article-title":"Long-term follow-up of cyclosporin-A-treated patients with Beh\u00e7et's disease","author":"Svenson","year":"1991"},{"key":"10.1053\/sarh.2001.19819_bib49","first-page":"435","article-title":"Sandimmun treatment of uveitis in Beh\u00e7et's disease","author":"Prokaeva","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib50","first-page":"432","article-title":"Cyclosporin in the management of Palestinian patients with Beh\u00e7et's disease","author":"Kanawati","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib51","first-page":"83","article-title":"Terapia con ciclosporina A dell'uveite endogena e delle manifestazioni oftalmologiche della malattia di Beh\u00e7et","author":"Scorrano","year":"1991"},{"key":"10.1053\/sarh.2001.19819_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0190-9622(08)81809-9","article-title":"Cyclosporine therapy in Beh\u00e7et's disease","volume":"29","author":"Suss","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF02249016","article-title":"Cyclosporin in Beh\u00e7et's disease: results in 16 patients after 24 months of therapy","volume":"13","author":"Pacor","year":"1994","journal-title":"Clin Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib54","first-page":"245","article-title":"Beh\u00e7et's disease: report of a case with refractory ocular manifestations and response to cyclosporine (Sandimmun) therapy","author":"Rajaee","year":"1998"},{"key":"10.1053\/sarh.2001.19819_bib55","first-page":"603","article-title":"Low-dose cyclosporin in Beh\u00e7et's disease: follow-up controlled study with emphasis on extraocular manifestations and neuro-Beh\u00e7et's disease","author":"Assaad-Khalil","year":"1991"},{"key":"10.1053\/sarh.2001.19819_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","article-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Beh\u00e7et's disease","volume":"118","author":"Whitcup","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1053\/sarh.2001.19819_bib57","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine A in Beh\u00e7et's syndrome","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1053\/sarh.2001.19819_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/000348949110000607","article-title":"Effect of cyclosporine A on the hearing loss in Beh\u00e7et's disease","volume":"100","author":"Elidan","year":"1991","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1053\/sarh.2001.19819_bib59","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-4362.1997.tb03133.x","article-title":"Topical cyclosporine-A for treatment of oral ulcers of Beh\u00e7et's syndrome","volume":"36","author":"Ergun","year":"1997","journal-title":"Intern J Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Beh\u00e7et's syndrome: a single masked trial","volume":"76","author":"Ozyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1053\/sarh.2001.19819_bib61","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archopht.1970.00990040448008","article-title":"Treatment of Beh\u00e7et's disease with chlorambucil","volume":"84","author":"Mamo","year":"1970","journal-title":"Arch Ophthalmol"},{"key":"10.1053\/sarh.2001.19819_bib62","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/bjo.57.9.706","article-title":"Long-lasting remission of Beh\u00e7et's disease after chlorambucil therapy","volume":"57","author":"Abdalla","year":"1973","journal-title":"Br J Ophthalmol"},{"key":"10.1053\/sarh.2001.19819_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","article-title":"Chlorambucil in the treatment of uveitis and meningoencephalitis of Beh\u00e7et's disease","volume":"76","author":"O'Duffy","year":"1984","journal-title":"Am J Med"},{"key":"10.1053\/sarh.2001.19819_bib64","article-title":"Treatment of Beh\u00e7et's disease with chlorambucil","author":"Matteson","year":"151989"},{"key":"10.1053\/sarh.2001.19819_bib65","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM199002013220509","article-title":"Beh\u00e7et's syndrome","volume":"322","author":"O'Duffy","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1053\/sarh.2001.19819_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00002281-199401000-00007","article-title":"Beh\u00e7et's disease","volume":"6","author":"O'Duffy","year":"1994","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/sarh.2001.19819_bib68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Beh\u00e7et's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib69","first-page":"145","article-title":"The management of Beh\u00e7et's syndrome: how are we doing?","volume":"17","author":"Yazici","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002281-199901000-00009","article-title":"Beh\u00e7et's syndrome","volume":"11","author":"Yazici","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib71","first-page":"236","article-title":"Azathioprine for the treatment of ophthalmological lesions of Beh\u00e7et's disease (abstr)","author":"Davatchi","year":"1998"},{"key":"10.1053\/sarh.2001.19819_bib72","first-page":"569","article-title":"Pulse cyclophosphamide in Beh\u00e7et's disease","author":"Fain","year":"1991"},{"key":"10.1053\/sarh.2001.19819_bib73","first-page":"555","article-title":"Pulse cyclophosphamide in ophthalmic manifestations of Beh\u00e7et's disease","author":"Davatchi","year":"1991"},{"key":"10.1053\/sarh.2001.19819_bib74","first-page":"475","article-title":"Efficacy of cyclophosphamide therapy in audiologic involvement of Beh\u00e7et's syndrome","author":"Taglione","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib75","first-page":"248","article-title":"Combination therapy with low dose pulse cyclophosphamide and methotrexate in ocular lesions of Beh\u00e7et's disease (abstr)","author":"Shahram","year":"1998"},{"key":"10.1053\/sarh.2001.19819_bib76","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2214\/ajr.172.3.10063870","article-title":"CT findings of pulmonary artery aneurysms during treatment for Beh\u00e7et's disease","volume":"172","author":"Tunaci","year":"1999","journal-title":"AJR Am J Roentgenol"},{"issue":"suppl","key":"10.1053\/sarh.2001.19819_bib77","first-page":"S320","article-title":"Pulse cyclophosphamide (PCP) for ocular lesions of Beh\u00e7et's disease: double blind crossover study (abstr)","volume":"42","author":"Davatchi","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib78","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF03259272","article-title":"Beh\u00e7et's syndrome: how should we treat it?","volume":"3","author":"Yazici","year":"1995","journal-title":"Clin Immunother"},{"key":"10.1053\/sarh.2001.19819_bib79","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(82)91268-5","article-title":"Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Beh\u00e7et's syndrome and recurrent oral ulcers","volume":"2","author":"Eglin","year":"1982","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib80","first-page":"6","article-title":"CD4 and CD8 cell responses to herpes simplex virus in Beh\u00e7et's disease","volume":"73","author":"Young","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/sarh.2001.19819_bib81","first-page":"338","article-title":"Lack of association between chronic hepatitis C virus infections and Beh\u00e7et's disease","volume":"15","author":"Cantini","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib82","first-page":"1938","article-title":"Interferon-\u03b1 treatment of Beh\u00e7et's disease","volume":"25","author":"O'Duffy","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib83","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","article-title":"Treatment of Adamantiades-Beh\u00e7et's disease with systemic interferon alpha","volume":"134","author":"Zouboulis","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib84","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00407749","article-title":"Beh\u00e7et's syndrome: treatment with recombinant leukocyte alfa-interferon","volume":"278","author":"Tsambaos","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1053\/sarh.2001.19819_bib85","first-page":"97","article-title":"Morbus Beh\u00e7et und exogenes interferon: erfolgreicher behandlungsversuch mit recombiniertem \u03b1-A-IFN","volume":"38","author":"Stadler","year":"1987","journal-title":"Hautarzt"},{"key":"10.1053\/sarh.2001.19819_bib86","first-page":"453","article-title":"Therapeutischer einsatz von a-interferon bei metastasierendem melignem melanom, disseminiertem Kaposi-sarkom und schwerem Morbus Beh\u00e7et","volume":"38","author":"Stadler","year":"1987","journal-title":"Hautarzt"},{"key":"10.1053\/sarh.2001.19819_bib87","first-page":"440","article-title":"Morbus Adamantiades-Beh\u00e7et. Therapeutischer Einsatz von systemischem rekombinantem interferon-a-2a","volume":"44","author":"Zouboulis","year":"1993","journal-title":"Hautarzt"},{"key":"10.1053\/sarh.2001.19819_bib88","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0190-9622(94)70226-8","article-title":"Interferon therapy for Beh\u00e7et's disease","volume":"31","author":"Alpsoy","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib89","first-page":"313","article-title":"Erosive arthritis and posterior uveitis in Beh\u00e7et's disease. Treatment with interferon \u03b1 and interferon \u03b3","volume":"14","author":"K\u00f6tter","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib90","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1056\/NEJM199502093320616","article-title":"Possible association between Beh\u00e7et's syndrome and chronic hepatitis C virus infection","volume":"332","author":"Munke","year":"1995","journal-title":"New Engl J Med"},{"key":"10.1053\/sarh.2001.19819_bib91","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000246374","article-title":"Interferon alpha-2a in the treatment of Beh\u00e7et's disease","volume":"192","author":"Azizlerli","year":"1996","journal-title":"Dermatology"},{"key":"10.1053\/sarh.2001.19819_bib92","first-page":"559","article-title":"Systemic interferon-alfa in the treatment of Adamantiades-Beh\u00e7et's disease","volume":"53","author":"Zouboulis","year":"1996"},{"key":"10.1053\/sarh.2001.19819_bib93","first-page":"477","article-title":"L'alfa-interferone nella malattia di Beh\u00e7et","volume":"42","author":"Massaro","year":"1996","journal-title":"Riv Neurobiol"},{"key":"10.1053\/sarh.2001.19819_bib94","first-page":"447","author":"K\u00f6tter","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib95","first-page":"456","article-title":"Alfa interferon therapy in Beh\u00e7et's disease related uveitis: report of two cases","author":"Lumbroso","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib96","first-page":"453","article-title":"The long-term treatment with interferon alpha-2A in Beh\u00e7et's disease","author":"Azizlerli","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib97","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/S0140-6736(97)10114-3","article-title":"Loss of vision and diarrhoea","volume":"350","author":"Grimbacher","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib98","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/art.1780360721","article-title":"Beneficial effects of interferon-alpha 2b in Beh\u00e7et's disease","volume":"36","author":"Durand","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(94)91371-4","article-title":"Interferon alpha-2B for refractory ocular Beh\u00e7et's disease","volume":"344","author":"Durand","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib100","first-page":"1098","article-title":"Systemic interferon a2b treatment in Beh\u00e7et's syndrome","volume":"21","author":"Hamuryudan","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib101","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(94)92549-6","article-title":"Interferon-alpha 2b for refractory ocular Behcet's disease (letter)","volume":"343","author":"Feron","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.19819_bib102","first-page":"285","article-title":"Alpha interferon in Beh\u00e7et's disease","volume":"9","author":"Dundar","year":"1996","journal-title":"Hematol Rev"},{"key":"10.1053\/sarh.2001.19819_bib103","first-page":"293","article-title":"Utilizacion de interferon alfa 2r en el tratamiento de las uveitis autoimmunes (primarias a associadas a enfermedad de Beh\u00e7et)","volume":"196","author":"Sanchez Roman","year":"1996","journal-title":"Rev Clin Esp"},{"key":"10.1053\/sarh.2001.19819_bib104","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-0420.1997.tb00638.x","article-title":"Interferon a for ocular Beh\u00e7et's disease","volume":"75","author":"Pivetti-Pezzi","year":"1997","journal-title":"Acta Ophthal Scand"},{"key":"10.1053\/sarh.2001.19819_bib105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2796.1998.00159.x","article-title":"Efficacy and safety of systemic recombinant interferon-alpha in Beh\u00e7et's disease","volume":"243","author":"Georgiou","year":"1998","journal-title":"J Intern Med"},{"issue":"suppl","key":"10.1053\/sarh.2001.19819_bib106","first-page":"S355","article-title":"Treatment of ocular Beh\u00e7et's disease (BD) with recombinant human interferon-\u00e12\u00e1 (rhIFN-\u00e12\u00e1)\u2014a three center pilot study (abstr)","volume":"41","author":"K\u00f6tter","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib107","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/rheumatology\/30.5.395-a","article-title":"Inefficacy of topical alpha interferon in the treatment of oral ulcers of Beh\u00e7et's syndrome: a randomized, double blind trial","volume":"30","author":"Hamuryudan","year":"1991","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002770050255","article-title":"Beh\u00e7et's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Beh\u00e7et's symptoms","volume":"74","author":"Budak-Alpdogan","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1053\/sarh.2001.19819_bib109","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(91)70156-V","article-title":"Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Beh\u00e7et's disease","volume":"24","author":"Jorizzo","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"suppl","key":"10.1053\/sarh.2001.19819_bib110","first-page":"S233","article-title":"Low dose weekly methotrexate therapy for progressive neuro-Beh\u00e7et's syndrome: a follow up study for 36 months (abstr)","volume":"41","author":"Ishi","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"suppl","key":"10.1053\/sarh.2001.19819_bib111","first-page":"S356","article-title":"Methotrexate for ocular lesions of Beh\u00e7et's disease. Cohort study on 262 patients (abstr)","volume":"41","author":"Davatchi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib112","first-page":"179","article-title":"Methotrexate in the treatment of ocular lesions of Beh\u00e7et's disease in children (abstr)","author":"Shafaie","year":"1998"},{"key":"10.1053\/sarh.2001.19819_bib113","first-page":"466","article-title":"Clinical trial of sulfasalazine for treatment of uveitis in Beh\u00e7et's disease","author":"Samangooei","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib114","first-page":"143","article-title":"Clinical and immunohistological studies on intestinal Beh\u00e7et's disease","volume":"1","author":"Mori","year":"1986","journal-title":"Jpn J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib115","first-page":"645","article-title":"Penicillin in treatment of Beh\u00e7et's disease","author":"Okten","year":"1991"},{"key":"10.1053\/sarh.2001.19819_bib116","first-page":"185","article-title":"Benzathine-penicillin in the prophylaxis and treatment of Beh\u00e7et's disease","author":"Haznedaroglu","year":"1994"},{"key":"10.1053\/sarh.2001.19819_bib117","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/art.1780391216","article-title":"The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Beh\u00e7et's disease. A randomized clinical trial","volume":"39","author":"Calguneri","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib118","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000246336","article-title":"Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Beh\u00e7et's disease","volume":"192","author":"Calguneri","year":"1996","journal-title":"Dermatology"},{"key":"10.1053\/sarh.2001.19819_bib119","first-page":"481","article-title":"Minocycline effects on the clinical symptoms in correlation with cytokines produced by peripheral blood mononuclear cells stimulated with streptococcal antigens in Beh\u00e7et's disease","author":"Oyama","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2796.1990.tb00253.x","article-title":"Treatment of severe colitis in Beh\u00e7et's syndrome with thalidomide (CG-217)","volume":"228","author":"Larsson","year":"1990","journal-title":"J Intern Med"},{"key":"10.1053\/sarh.2001.19819_bib121","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02054255","article-title":"Treatment of Beh\u00e7et's disease with thalidomide","volume":"5","author":"Hamza","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib122","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archinte.1986.00360170074012","article-title":"Thalidomide effects in Beh\u00e7et's syndrome and pustular vasculitis","volume":"146","author":"Jorizzo","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1053\/sarh.2001.19819_bib123","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archderm.1982.01650200004003","article-title":"Thalidomide in the treatment of Beh\u00e7et's syndrome (letter)","volume":"118","author":"Saylan","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib124","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.53.12.828","article-title":"Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Beh\u00e7et's disease: use of neurophysiological studies to detect thalidomide neuropathy","volume":"53","author":"Gardner-Medwin","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sarh.2001.19819_bib125","first-page":"649","article-title":"Low dose thalidomide treatment of Beh\u00e7et's syndrome","author":"Denman","year":"1992"},{"key":"10.1053\/sarh.2001.19819_bib126","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0190-9622(89)70132-8","article-title":"Treatment of aphthae with thalidomide","volume":"20","author":"Grispan","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib127","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000249696","article-title":"Treatment de l'aphthoses par la thalidomide et la colchicine","volume":"168","author":"Genvo","year":"1984","journal-title":"Dermatologica"},{"key":"10.1053\/sarh.2001.19819_bib128","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.1990.01670310085012","article-title":"Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/sarh.2001.19819_bib130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0248-8663(99)80105-2","article-title":"Traitement de l'aphthose recurrence par thalidomide \u00e0 faible dose. Etude pilote chez 17 patients","volume":"20","author":"Wazieres de","year":"1999","journal-title":"Rev Med Interne"},{"key":"10.1053\/sarh.2001.19819_bib131","doi-asserted-by":"crossref","first-page":"494","DOI":"10.7326\/0003-4819-128-6-199803150-00011","article-title":"Beh\u00e7et disease and the emergence of thalidomide","volume":"128","author":"Ehrlich","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/sarh.2001.19819_bib132","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2133.1984.tb04665.x","article-title":"Suppression of Beh\u00e7et's disease with dapsone","volume":"110","author":"Sharquie","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib133","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02031080","article-title":"Treatment of Beh\u00e7et's disease with dapsone","volume":"8","author":"Hamza","year":"1989","journal-title":"Clin Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib134","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-124-10-199605150-00005","article-title":"Successful treatment of Beh\u00e7et's disease with pentoxifylline","volume":"124","author":"Yasui","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/sarh.2001.19819_bib135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(99)70431-2","article-title":"Beh\u00e7et's disease in children","volume":"134","author":"Yasui","year":"1999","journal-title":"J Pediatr"},{"key":"10.1053\/sarh.2001.19819_bib136","first-page":"247","article-title":"Successful treatment of ischemic leg ulcer in a patient with occlusive vasculo-Beh\u00e7et's syndrome with pentoxifillin (abstr)","author":"Samangooei","year":"1998"},{"key":"10.1053\/sarh.2001.19819_bib137","first-page":"291","article-title":"The therapeutic and immunological effects of levamisole in recurrent oral ulcers and Beh\u00e7et's syndrome","author":"Lehner","year":"1979"},{"key":"10.1053\/sarh.2001.19819_bib138","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.1780240111","article-title":"Treatment of Beh\u00e7et's syndrome with levamisole","volume":"24","author":"De Merieux","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib139","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.1780250621","article-title":"Treatment of Beh\u00e7et's disease with levamisole","volume":"25","author":"Hamza","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.19819_bib140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2133.1997.tb02170.x","article-title":"Local intralesional therapy with rhGM-CSF for a large genital ulcer in Beh\u00e7et's disease","volume":"136","author":"Alli","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib141","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1079-2104(97)90009-3","article-title":"5% Amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers. I. Clinical demonstration of acceleration of healing and resolution of pain","volume":"83","author":"Khandwala","year":"1997","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1053\/sarh.2001.19819_bib142","first-page":"477","article-title":"The beneficial effect of rebamipide on recurrent oral aphthous ulcers in Beh\u00e7et's disease","author":"Tanaka","year":"1997"},{"key":"10.1053\/sarh.2001.19819_bib143","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archderm.135.5.529","article-title":"The use of sucralfate suspension in the treatment of oral and genital ulceration of Beh\u00e7et's disease. A randomized, placebo-controlled, double-blind study","volume":"135","author":"Alpsoy","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1053\/sarh.2001.19819_bib144","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bdj.4809326","article-title":"Use of proprietary agents to relieve recurrent aphthous stomatitis","volume":"182","author":"Edres","year":"1997","journal-title":"Br Dent J"},{"key":"10.1053\/sarh.2001.19819_bib145","first-page":"576","article-title":"The management of Beh\u00e7et's syndrome","volume":"150","author":"Fresco","year":"1999","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1053\/sarh.2001.19819_bib146","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-857X(21)01067-X","article-title":"Vasculitis in Beh\u00e7et's disease","volume":"16","author":"O'Duffy","year":"1990","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1053\/sarh.2001.19819_bib147","first-page":"92","article-title":"Therapy of Beh\u00e7et's disease","volume":"5","author":"K\u00f6tter","year":"1996","journal-title":"Germ J Ophthamol"},{"issue":"suppl 1","key":"10.1053\/sarh.2001.19819_bib148","first-page":"73(P)S-024","article-title":"Treatment of severe uveitis of Beh\u00e7et's syndrome with the combination of Interferon-\u00e12B and azathioprine. An open study","volume":"59","author":"Hamuryudan","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sarh.2001.19819_bib149","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rheumatology\/35.2.139","article-title":"The ten-year mortality in Beh\u00e7et's syndrome","volume":"35","author":"Yazici","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.19819_bib150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","article-title":"Treatment and visual prognosis in Beh\u00e7et's disease","volume":"70","author":"BenEzra","year":"1986","journal-title":"Br J Ophthalmol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017201608114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017201608114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T04:58:27Z","timestamp":1682139507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017201608114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0049017201608114"],"URL":"https:\/\/doi.org\/10.1053\/sarh.2001.19819","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}